Clinical Trial Update: Chemotherapy Omission in ER+/HER2- Breast Cancer With 1-3 Positive Lymph Nodes Receiving Extended Adjuvant Abemaciclib [Phase 3]

View source ↗

Summary

Phase 3 trial investigating chemotherapy omission with extended adjuvant abemaciclib in ER+/HER2- breast cancer with 1-3 positive lymph nodes; currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abemaciclib (abemaciclib)

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Phase 3 | Status: RECRUITING